Vizcaya, Spain

Ana Gonzalo Gorostiza

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ana Gonzalo Gorostiza: Innovator in Pharmaceutical Compositions

Introduction

Ana Gonzalo Gorostiza is a prominent inventor based in Vizcaya, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. Her work focuses on enhancing treatment options for various disorders through her inventive solutions.

Latest Patents

Ana holds a patent for an invention titled "Aqueous compositions comprising bilastine and mometasone." This aqueous pharmaceutical composition is designed for the treatment and prevention of disorders that can be improved by antagonism of histamine receptors and corticosteroid-responsive diseases. The invention also details a process for preparing this pharmaceutical composition, emphasizing its application through nasal administration.

Career Highlights

Ana is associated with Faes Farma, S.A., a well-known company in the pharmaceutical industry. Her role at the company has allowed her to focus on research and development, leading to her innovative contributions in the field. With a patent portfolio that includes 1 patent, she continues to push the boundaries of pharmaceutical science.

Collaborations

Ana has collaborated with notable colleagues such as Gonzalo Hernández Herrero and Neftalí García Domínguez. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective pharmaceutical solutions.

Conclusion

Ana Gonzalo Gorostiza is a trailblazer in the pharmaceutical industry, with her innovative compositions paving the way for improved treatments. Her dedication to research and collaboration exemplifies the spirit of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…